A groundbreaking discovery in the fight against sepsis, a leading global killer, has emerged from Australian research. The study, led by experts from the University of Adelaide and the Central Adelaide Local Health Network, reveals a naturally occurring protein that could be a game-changer. This protein, known as corticosteroid-binding globulin (CBG), has shown remarkable potential in reducing sepsis-related deaths by over 70% in animal models.
Dr. Stewart Ramsay, the lead author and a Research Fellow at Adelaide University's School of Medicine, emphasizes the significance of these findings: "Our preclinical study results are truly remarkable, indicating a significant reduction in sepsis-related deaths. This is a massive leap forward in our quest for a new sepsis treatment, especially for septic shock, which accounts for a staggering 20% of global deaths."
But here's where it gets intriguing: CBG, a protein produced in the liver, plays a crucial role in transporting the stress hormone cortisol through the bloodstream. Researchers have dedicated over a decade to studying this protein, and their efforts have paid off. Earlier studies linked CBG deficiency to more severe illnesses and a threefold increase in mortality risk among intensive care patients with septic shock at the Royal Adelaide Hospital.
Associate Professor Richard Young, a Senior Research Fellow at Adelaide University and SAHMRI, highlights the recent study's impact: "Our latest preclinical study demonstrated marked protection against sepsis progression, with significant reductions in hypotension and organ damage. This suggests that CBG triggers an anti-inflammatory response beyond its known function, potentially making it the first natural anti-inflammatory discovered in decades."
So, what exactly is sepsis? It's a life-threatening condition where the body's immune system goes into overdrive while fighting an infection. In severe cases, it can lead to septic shock, causing a dangerous drop in blood pressure and multiple organ failures. The World Health Organization (WHO) recognizes sepsis as a global health priority, and researchers anticipate an increase in sepsis cases due to advancements in invasive surgeries, implantable devices, and immunosuppressive therapies.
Professor David Torpy, a Professor of Medicine at Adelaide University and Head of the Royal Adelaide Hospital Endocrine and Metabolic Unit, emphasizes the urgency: "Septic shock demands new treatments. Despite the high mortality rate, there have been no new septic shock therapies introduced for decades, and existing treatments have limited success. This natural therapy has the potential to save lives in sepsis and septic shock patients, with minimal toxicity."
The research team, in collaboration with Dr. Jessica Lee from AusHealth, is now producing CBG for the first-in-human clinical trials. Dr. Ramsay expresses optimism: "We believe this natural therapy could benefit patients with severe burn injuries and other conditions where CBG is severely depleted, beyond its impact on sepsis."
This research offers a glimmer of hope in the battle against sepsis, and we eagerly await the outcomes of the upcoming clinical trials. What are your thoughts on this potential breakthrough? Do you think natural therapies like CBG could be the key to tackling sepsis and other life-threatening conditions? Share your insights and let's spark a discussion on this promising development!
